↓ Skip to main content

Aripiprazole for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
11 X users
weibo
1 weibo user

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
148 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aripiprazole for schizophrenia
Published in
Cochrane database of systematic reviews, April 2006
DOI 10.1002/14651858.cd004578.pub3
Pubmed ID
Authors

Hany George El‐Sayeh, Carla Morganti

Abstract

Treatment of people with schizophrenia using older typical antipsychotic drugs such as haloperidol can be problematic. Many fail to respond to these older antipsychotics and more people experience disabling adverse effects. Aripiprazole is said to be one of a new generation of atypical antipsychotics with good antipsychotic properties and minimal adverse effects.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 148 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
Spain 1 <1%
United States 1 <1%
Norway 1 <1%
Unknown 143 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 16%
Student > Bachelor 20 14%
Researcher 18 12%
Student > Ph. D. Student 12 8%
Student > Doctoral Student 10 7%
Other 26 18%
Unknown 38 26%
Readers by discipline Count As %
Medicine and Dentistry 54 36%
Psychology 12 8%
Nursing and Health Professions 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Neuroscience 6 4%
Other 17 11%
Unknown 41 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2022.
All research outputs
#1,777,362
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,794
of 11,499 outputs
Outputs of similar age
#3,254
of 84,969 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 47 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 84,969 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.